Head Topics

HER2- Breast Cancer News

Latest News On HER2- Breast Cancer

Datroway Gains Second FDA Nod With NSCLC Approval

Datroway Gains Second FDA Nod With NSCLC Approval

6/23/2025 5:27 PM
Oncology Is a Team Sport: ASCO Panel Highlights Multidisciplinary Collaboration

Oncology Is a Team Sport: ASCO Panel Highlights Multidisciplinary Collaboration

6/13/2025 9:45 AM
A New Era of Locoregional Treatment in Early-Stage Breast Cancer

A New Era of Locoregional Treatment in Early-Stage Breast Cancer

5/19/2025 11:18 AM
Rethinking the Scalpel: Advancing Non-Surgical Strategies for Early Breast Cancer

Rethinking the Scalpel: Advancing Non-Surgical Strategies for Early Breast Cancer

5/5/2025 9:49 AM
Trastuzumab Emtansine Ups Long-Term Survival in HER2-Positive Breast Cancer

Trastuzumab Emtansine Ups Long-Term Survival in HER2-Positive Breast Cancer

1/16/2025 9:15 AM
Immediate Surgery Significantly Improves Long-Term Survival in Older Breast Cancer Patients, Meta-Analysis Shows

Immediate Surgery Significantly Improves Long-Term Survival in Older Breast Cancer Patients, Meta-Analysis Shows

12/12/2024 4:24 AM
Inside the Patient-Oncologist Bond: Why It’s Often So Strong

Inside the Patient-Oncologist Bond: Why It’s Often So Strong

11/26/2024 6:40 AM
Q&A: HER2- Low Breast Cancer Pathophysiology and Evidence-Based Treatment Approaches

Q&A: HER2- Low Breast Cancer Pathophysiology and Evidence-Based Treatment Approaches

10/17/2024 12:49 PM
FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer

FDA OKs Adjuvant Ribociclib in Earlier Stage Breast Cancer

9/19/2024 5:37 AM


Render Time: 2026-04-29 07:45:38